Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-25T13:47:57.899Z Has data issue: false hasContentIssue false
  • English
  • Français

Gloucester Clozapine Clinic

Published online by Cambridge University Press:  02 January 2018

Rob Macpherson ,
Sarbani Prasad Sarkar ,
Juan L. Medina-Galera  and
Bryan Anstee
Rob Macpherson*
Affiliation:
Wotton Lawn, Horton Road, Gloucester, GL1 3PX
Sarbani Prasad Sarkar
Affiliation:
Wotton Lawn, Horton Road, Gloucester, GL1 3PX
Juan L. Medina-Galera
Affiliation:
Wotton Lawn, Horton Road, Gloucester, GL1 3PX
Bryan Anstee
Affiliation:
Llanarth, Raglan, Gwent, NP5 2YD
*
∗Correspondence
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Twenty-four patients in the Gloucester rehabilitation service were considered suitable for clozapine treatment between January 1993 and May 1996. Five patients consistently refused to start clozapine and four patients (21%) discontinued clozapine, usually due to side-effects. Eight patients showed ‘some positive response’ and seven ‘good positive response’, of the 15 still taking clozapine. High rates of side-effects, but low readmission rates were found in this group. Putative reasons for the low discontinuation rates and apparent success of clozapine treatment in Gloucester include the wide experience engendered in the single consultant-led rehabilitation team, and the better coordinated, uniform approach to managing problems through the Clozapine Clinic.

Type
Original Papers
Information
Psychiatric Bulletin , Volume 22 , Issue 5 , May 1998 , pp. 300 - 302
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1998 The Royal College of Psychiatrists

References

Davis, L. M. & Drummond, M. F. (1994) Economics and schizophrenia: the real cost. British Journal of Psychiatry, 165 (suppl. 25), 18–21.Google Scholar
Kane, J., Honigfeld, G., Singer, J., et al (1988) Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789–796.Google Scholar
King, D. J. & Mills, P. J. (1993) Clozapine: The Holywell experience with the first 24 patients. Irish Journal of Psychosocial Medicine, 10, 30–34.CrossRefGoogle Scholar
Meltzer, H. Y., Burnett, S., Bastani, B., et al (1990) Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hospital and Community Psychiatry, 41, 892–897.Google ScholarPubMed
Overall, J. E. & Gorham, D. R. (1962) The Brief Psychiatric Rating Scale. Psychological Reports, 10, 799–812.Google Scholar
Seabourne, A. & Thomas, C. S. (1994) The use of clozapine in South Manchester. Psychiatric Bulletin, 18, 618–619.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.